Search & Filter
Bills & Legislation
BILLH.R. 1195Health
Protect Medicaid Act
Richard Hudson (R-NC)Feb 11, 2025
BILLH.R. 1221Health
Social Security and Medicare Lock-Box Act
Tim Walberg (R-MI)Feb 11, 2025
BILLS. 502Health
Rural Hospital Closure Relief Act of 2025
Richard J. Durbin (D-IL)Feb 10, 2025
BILLS. 494Health
National Plan for Epilepsy Act
Eric Schmitt (R-MO)Feb 10, 2025
BILLH.R. 1171Health
SAFE Act
Carol D. Miller (R-WV)Feb 10, 2025
BILLH.R. 1178Health
Alpha-gal Allergen Inclusion Act
Jefferson Van Drew (R-NJ)Feb 10, 2025
BILLH.R. 1162Health
Medicaid Primary Care Improvement Act
Dan Crenshaw (R-TX)Feb 10, 2025
BILLH.R. 1157Health
ACCESS Act
W. Gregory Steube (R-FL)Feb 10, 2025
BILLH.R. 1153Health
Rural Physician Workforce Production Act of 2025
Diana Harshbarger (R-TN)Feb 10, 2025
BILLS. 501Health
Strategy for Public Health Preparedness and Response to Artificial Intelligence Threats
Ted Budd (R-NC)Feb 10, 2025
BILLH.R. 1127Health
Rural America Health Corps Act
David Kustoff (R-TN)Feb 7, 2025
BILLH.R. 1143Health
Medicare IVIG Access Enhancement Act of 2025
Adrian Smith (R-NE)Feb 7, 2025
BILLH.R. 1117Health
Responsibility in Drug Advertising Act of 2025
Rosa L. DeLauro (D-CT)Feb 7, 2025
BILLH.R. 1108Health
Diagnostics Testing Preparedness Plan Act of 2025
Mariannette Miller-Meeks (R-IA)Feb 7, 2025
BILLH.R. 1142Health
To amend the Public Health Service Act to direct the Secretary of Health and Human Services to establish drug adherence guidelines, and for other purposes.
David Schweikert (R-AZ)Feb 7, 2025
BILLH.R. 1126Health
East Palestine Health Impact Monitoring Act of 2025
David P. Joyce (R-OH)Feb 7, 2025
BILLH.R. 1141Health
Gambling Addiction Recovery, Investment, and Treatment Act
Andrea Salinas (D-OR)Feb 7, 2025
BILLH.R. 1060Health
Modern Authentication of Pharmaceuticals Act of 2025
Donald G. Davis (D-NC)Feb 6, 2025
BILLS.Res. 67Health
A resolution declaring racism a public health crisis.
Cory A. Booker (D-NJ)Feb 6, 2025
BILLH.R. 1051Health
To amend the Federal Food, Drug, and Cosmetic Act to allow for the approval of an abbreviated new drug application submitted by a subsequent applicant in the case of a failure by a first applicant to commence commercial marketing within a certain period, and for other purposes.
Nikki Budzinski (D-IL)Feb 6, 2025